These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 19930845)
1. Inhibition of the replication of hepatitis B virus in vitro by oxymatrine. Lin M; Yang LY; Li WY; Peng YP; Zheng JK J Int Med Res; 2009; 37(5):1411-9. PubMed ID: 19930845 [TBL] [Abstract][Full Text] [Related]
2. [Thymopolypeptides combined with matrine type alkaloids suppress HBV replication]. Liu XQ; Shen HH; Chen JX; Bai ZF; Wang JB; Xiao XH Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1275-1281. PubMed ID: 28879743 [TBL] [Abstract][Full Text] [Related]
3. Anti-hepatitis B virus effect of matrine-type alkaloid and involvement of p38 mitogen-activated protein kinase and tumor necrosis factor receptor-associated factor 6. Chen JX; Shen HH; Niu M; Guo YM; Liu XQ; Han YZ; Zhang YM; Zhao YL; Bai BK; Zhou WJ; Xiao XH Virus Res; 2016 Apr; 215():104-13. PubMed ID: 26685094 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro. He YW; Guo CX; Pan YF; Peng C; Weng ZH World J Gastroenterol; 2008 Mar; 14(10):1592-7. PubMed ID: 18330954 [TBL] [Abstract][Full Text] [Related]
5. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein. Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212 [TBL] [Abstract][Full Text] [Related]
6. S-phase arrest after vincristine treatment may promote hepatitis B virus replication. Xu L; Tu Z; Xu G; Hu JL; Cai XF; Zhan XX; Wang YW; Huang Y; Chen J; Huang AL World J Gastroenterol; 2015 Feb; 21(5):1498-509. PubMed ID: 25663769 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo. Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860 [TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line. He W; Li LX; Liao QJ; Liu CL; Chen XL World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells. Huang KL; Lai YK; Lin CC; Chang JM World J Gastroenterol; 2006 Sep; 12(35):5721-5. PubMed ID: 17007029 [TBL] [Abstract][Full Text] [Related]
10. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment. Shi H; Lu L; Zhang NP; Zhang SC; Shen XZ World J Gastroenterol; 2012 Jul; 18(27):3617-22. PubMed ID: 22826629 [TBL] [Abstract][Full Text] [Related]
11. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro. Dai XQ; Cai WT; Wu X; Chen Y; Han FM Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115 [TBL] [Abstract][Full Text] [Related]
12. Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells. Li GQ; Xu WZ; Wang JX; Deng WW; Li D; Gu HX World J Gastroenterol; 2007 Apr; 13(16):2324-7. PubMed ID: 17511031 [TBL] [Abstract][Full Text] [Related]
13. Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro. Xu WS; Zhao KK; Miao XH; Ni W; Cai X; Zhang RQ; Wang JX World J Gastroenterol; 2010 Apr; 16(16):2028-37. PubMed ID: 20419842 [TBL] [Abstract][Full Text] [Related]
14. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus. Hu K; Huang Y; Mu J; Cheng Z; Zhu X Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell. Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501 [TBL] [Abstract][Full Text] [Related]
16. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell. Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880 [TBL] [Abstract][Full Text] [Related]
17. Sequential combination therapy leads to biochemical and histological improvement despite low ongoing intrahepatic hepatitis B virus replication. Lutgehetmann M; Volzt T; Quaas A; Zankel M; Fischer C; Dandri M; Petersen J Antivir Ther; 2008; 13(1):57-66. PubMed ID: 18389899 [TBL] [Abstract][Full Text] [Related]
18. Anti-HBV Activities of Three Compounds Extracted and Purified from Herpetospermum Seeds. Gong PY; Yuan ZX; Gu J; Tan R; Li JC; Ren Y; Hu S Molecules; 2016 Dec; 22(1):. PubMed ID: 28035986 [TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991 [TBL] [Abstract][Full Text] [Related]
20. The effect of mycophenolate acid on hepatitis B virus replication in vitro. Wu J; Xie HY; Jiang GP; Xu X; Zheng SS Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):410-3. PubMed ID: 14599949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]